G01N30/00

Devices to facilitate sampling with thin film solid phase microextraction
11092522 · 2021-08-17 ·

The present invention describes several embodiments of a device that allows for the supporting, storage and deployment of large surface area thin film solid phase microextraction (TF-SPME) chemical samplers from within a sample fluid carrier. The utility of said supporting device originates from the process by which the extraction surface is stabilised within a sample carrying fluid for the extraction of chemical molecules from said sample carrying fluid. The device is also characterized by having a seating cavity, and moving mechanism or cap that can switch the supported TF-SPME chemical sampler between an open, sampling position or closed storage position.

DEVICES, METHODS AND KITS FOR SAMPLE CHARACTERIZATION
20210223261 · 2021-07-22 ·

Devices and methods for characterization of samples are provided. Samples may comprise one or more analytes. Some methods described herein include performing enrichment steps on a device. Some methods described herein include performing mobilization of analytes. Analytes may then be further processed and characterized.

DEVICES, METHODS AND KITS FOR SAMPLE CHARACTERIZATION
20210223261 · 2021-07-22 ·

Devices and methods for characterization of samples are provided. Samples may comprise one or more analytes. Some methods described herein include performing enrichment steps on a device. Some methods described herein include performing mobilization of analytes. Analytes may then be further processed and characterized.

SEIZURE DETECTION DEVICE

A method of detecting a seizure includes collecting volatile organic compounds with a collector material of a collector; separating a mixture of the volatile organic compounds into its constituent chemicals with a gas chromatography column; ionizing the constituent chemicals to create ionized chemicals and detecting the ionized chemicals; and analyzing the ionized chemicals to identify seizure-indicative volatile organic compounds.

SEIZURE DETECTION DEVICE

A method of detecting a seizure includes collecting volatile organic compounds with a collector material of a collector; separating a mixture of the volatile organic compounds into its constituent chemicals with a gas chromatography column; ionizing the constituent chemicals to create ionized chemicals and detecting the ionized chemicals; and analyzing the ionized chemicals to identify seizure-indicative volatile organic compounds.

Materials for hydrophilic interaction chromatography and processes for preparation and use thereof for analysis of glycoproteins and glycopeptides

The invention relates to poly-amide bonded hydrophilic interaction chromatography (HILIC) stationary phases and novel HILIC methods for use in the characterization of large biological molecules modified with polar groups, known to those skilled in the art as glycans. The invention particularly provides novel, poly-amide bonded materials designed for efficient separation of large biomolecules, e.g. materials having a large percentage of larger pores (i.e. wide pores). Furthermore, the invention advantageously provides novel HILIC methods that can be used in combination with the stationary phase materials described herein to effectively separate protein and peptide glycoforms by eliminating previously unsolved problems, such as on-column aggregation of protein samples, low sensitivity of chromatographic detection of the glycan moieties, and low resolution of peaks due to restricted pore diffusion and long intra/inter-particle diffusion distances.

Differential diagnosis of liver disease

The disclosure relates to the substantially non-invasive diagnosis of liver disease, especially to enable intervention in the progression of such disease at an early stage. This invention further relates to the use of plasma biomarkers to differentiate nonalcoholic steatohepatitis (NASH) from nonalcoholic fatty liver (NAFL) and non-nonalcoholic fatty liver disease (NAFLD), and normal controls. Specifically, the invention relates to the use of free eicosanoids and other polyunsaturated fatty acid (PUFA) metabolite levels in plasma to differentiate NASH from NAFL and non-NAFLD normal controls.

Drug detection device

In a first aspect, there is a device for detecting a substance within blood, including a collecting tube dimensioned to draw in blood through capillary action; a reagent chamber containing a reactive element; and a connector tube providing fluid communication between the reagent chamber and the collecting tube; wherein the connector tubes are dimensioned to draw in blood through capillary action to the reagent chamber. In other aspects, the device can include an outer casing and/or a plurality of reagent chambers each with a reactive element therein.

Polymer microcolumn for gas or vapor separation, chromatography, and analysis

In an aspect, a method for forming a microcolumn comprises steps of: (a) providing a sacrificial fiber; (b) forming a microcolumn body around said sacrificial fiber; and (c) removing said sacrificial fiber from said microcolumn body such that a hollow channel is formed within said microcolumn body via removal of said sacrificial fiber. In any embodiment of the methods disclosed herein for forming a microcolumn, said hollow channel extends through said microcolumn body and is continuous between a first end and a second end. The first end may be an inlet and the second end may be an outlet, for example, allowing for a mobile phase to enter the hollow channel via the first end and exit via the second end.

Method for extracting and detecting volatile organic compounds

A method for extracting and detecting volatile organic compounds includes steps as follows. At least one effervescent tablet is provided, wherein the effervescent tablet is produced by mixing an acidic compound and an alkaline compound homogeneously. An extraction and detection apparatus is provided, wherein the extraction and detection apparatus includes an extraction chamber, an injection tube and a detection instrument. An extraction step is performed, wherein a liquid matrix is put into the extraction chamber, and the effervescent tablet is added into the liquid matrix to generate bubbles, the volatile organic compounds are extracted from the liquid matrix by the bubbles, and the bubbles enter into the headspace of the extraction chamber. A detection step is performed, wherein the volatile organic compounds extracted during the extraction step are transferred to the detection instrument via the injection tube so as to detect the volatile organic compounds.